A subscriber identification module (SIM) card is an integrated circuit (IC) that is intended to securely store the international mobile subscriber identity (IMSI) number, which is used to identify and authenticate subscribers on mobile telephony devices.

True wireless headphones are wireless audio devices that operate without any physical connection to audio sources. These headphones offer the freedom to enjoy music, podcasts, and other audio content without the constraints of wires, making them a popular choice for consumers seeking convenience and portability. True wireless headphones come in various forms including earbuds and headphones; they are equipped with advanced technologies such as Bluetooth connectivity for seamless pairing with mobile devices and active noise cancellation for immersive listening experiences. The market caters to a wide range of consumer preferences, with options available for different usage scenarios, styles, and budgets. With a focus on innovation and user experience, the true wireless headphones market continues to evolve, driven by the advancements in audio technology and changing consumer lifestyles.

The global truck axle market is a part of the global automotive parts and equipment market. The global automotive parts and equipment market was valued at $3,246.34 billion in 2021 and reached $3,407.01 billion in 2023. The global automotive parts and equipment market witnessed an incremental growth of $160.7 billion and registered a CAGR of 2.4% from 2021 to 2023.

Army Recognition - Lockheed Martin Invites Polish Industry to Participate in HIMARS Missile Production - 12/6/2024 Lockheed Martin has invited Poland’s defense industry to participate in producing guided multiple-launch rocket systems (GMLRS). For the complete story see:

Bloomberg Law News - Amgen Seeks Speedy Ruling Against Colorado Drug Pricing Board - 26/6/2024 Drugmaker Amgen Inc. will suffer “concrete harm” unless a federal judge quickly enjoins Colorado’s drug pricing board from moving forward with a payment cap for the autoimmune treatment Enbrel, the company argued in a filing.

Defense News - Northrop’s colossal Manta Ray underwater drone passes at-sea tests - 3/5/2024 Northrop Grumman’s massive Manta Ray underwater test bed completed at-sea trials this year, validating its ability to operate below the waves and with minimal human contact.

Business Insider – An airline startup that hopes to fly Airbus A380s between New York and London is delaying its launch to 2025 – 21/6/2024 UK startup Global Airlines wants to fly Airbus A380s across the Atlantic but already faces delays.

First and only BTK inhibitor to demonstrate favourable overall survival trend vs. standard-of-care chemoimmunotherapy in this setting Positive results from the ECHO Phase III trial showed AstraZeneca’s Calquence (acalabrutinib) in combination with bendamustine and rituximab demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) and showed a favourable trend in overall survival (OS) compared to standard-of-care chemoimmunotherapy (bendamustine plus rituximab) in previously untreated patients with mantle cell lymphoma (MCL). These results will be presented today in a late-breaking oral presentation at the European Hematology Association (EHA) 2024 Hybrid Congress in Madrid, Spain (#LBA3439).

RAHWAY, N.J.–(3BL MEDIA)–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Merck for Mothers, the company’s global maternal health initiative, has reached more than 30 million women through programs promoting safe, high-quality, respectful care, surpassing its goal of reaching 25 million women by 2025. Merck for Mothers supports the company’s work in expanding access to health and accelerating progress toward the United Nations’ Sustainable Development Goal 3 (SDG 3), which aims to ensure healthy lives and promote well-being for all. More specifically, the initiative is focused on creating a world where no woman has to die while giving life by helping to address the first target under SDG 3, reducing the global maternal mortality ratio to less than 70 per 100,000 live births by 2030.